Regulation of the receptor for TNFα, TNFR1, in human conjunctival epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 9, 2008, Pages 3992-3998

  Cook, Ellen B ^a   Stahl, James L ^a   Graziano, Frank M ^a   Barney, Neal P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; ADAM PROTEIN; HYDROXAMIC ACID; TAPI 2; TAPI-2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ARTICLE; CADAVER; CONJUNCTIVA; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EYE INFLAMMATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; SECRETION;

ADAM PROTEINS; CELL CULTURE TECHNIQUES; CONJUNCTIVA; CULTURE MEDIA; EPITHELIAL CELLS; HUMANS; HYDROXAMIC ACIDS; MAST CELLS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 53149151866     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1873     Document Type: Article

References (27)

1. Schultz BL. Pharmacology of ocular allergy. Curr Opin Allergy Clin Immunol. 2006;6:383-389.
2. Bitko V, Musiyenko A, Barik S. Viral infection of the lungs through the eye. J Virol. 2007;81:783-790. (Pubitemid 46067904)
3. Baudouin C, Liang H. Amplifying factors in ocular surface diseases: apoptosis. Ocul Surf. 2005;3(suppl):S194-S197.
4. Cook EB, Stahl JL, Barney NP, Graziano FM. Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells. Ann Allergy Asthma Immunol. 2001;87:424-429.
5. Bode L, Murch S, Freeze HH. Heparin sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J Biol Chem. 2006;281:7809-7815. (Pubitemid 43847395)
6. Xanthoulea S, Pasparakis M, Kousteni S, et al. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases. J Exp Med. 2004;200:367-376. (Pubitemid 39031255)
7. Diebold Y, Calonge M, Enríquez de Salamanca A, et al. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci. 2003;44:4263-4274. (Pubitemid 37186260)
8. Cook EB, Stahl JL, Miller S, et al. Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-alpha from mast cells affects intercellular adhesion molecule-1 expression on epithelial cells. Invest Ophthalmol Vis Sci. 1998;39:336-343. (Pubitemid 28093870)
9. Miller S, Cook EB, Graziano FM, Spellman J, Yanni J. Human conjunctival mast cell responses in vitro to various secretagogues. Ocul Immunol Inflamm. 1996;4:39-49. (Pubitemid 26053094)
10. Cook EB, Stahl JL, Barney NP, Graziano FM. Olopatadine inhibits TNFα release from human conjunctival mast cells. Ann Allergy Asthma Immunol. 2000;84:504-508. (Pubitemid 30365412)
11. Hingorani M, Calder VL, Buckley RJ, Lightman SL. The role of conjunctival epithelial cells in chronic ocular allergic disease. Exp Eye Res. 1998;67:491-500. (Pubitemid 29005145)
12. Whitcup SM, Chan CC, Kozhich AT, Magone MT. Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis. Clin Immunol. 1999;93:107-113.
13. Liang H, Baudouin C, Labbé A, et al. In vivo confocal microscopy and ex vivo flow cytometry: new tools for assessing ocular inflammation applied to rabbit lipopolysaccharide-induced conjunctivitis. Mol Vis. 2006;12:1392-1402. (Pubitemid 44932833)
14. Sippy BD, Hofman FM, Wright AD, et al. Induction of intercellular adhesion molecule-1 by tumor necrosis factor-alpha through the 55-kDa receptor is dependent on protein kinase C in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1996;37:597-606. (Pubitemid 26077679)
15. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 1999;17:331-367. (Pubitemid 29241128)
16. Rothe J, Lesslauer W, Lötscher H, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993;364:798-802. (Pubitemid 23261759)
17. Pfeffer K, Matsuyama T, Kündig TM, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 1993;73:457-467. (Pubitemid 23143346)
18. Fessler SP, Chin YR, Horwitz MS. Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1. J Virol. 2004;78:13113-13121.
19. Dri P, Gasparini C, Renzo M, et al. TNF-induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase. J Immunol. 2000;165:2165-2172. (Pubitemid 30643166)
20. Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massagué J. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem. 1996;271:11376-11382. (Pubitemid 26155976)
21. Marin V, Montero-Julian F, Grès S, Bongrand P, Farnarier C, Kaplanski G. Chemotactic agents induce IL-6Rα shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-α-converting enzyme (TACE) type. Eur J Immunol. 2002;32:2965-2970. (Pubitemid 35238189)
22. Peschon JJ, Slack JL, Reddy P, et al. An essential role for ectodomain shedding in mammalian development. Science. 1998;282:1281-1284. (Pubitemid 28524483)
23. Brou C, Logeat F, Gupta N, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell. 2000;5:207-216. (Pubitemid 30628080)
24. Rovida E, Paccagnini A, Del Rosso M, Peschon J, Dello Sbarba P. TNF-α-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J Immunol. 2001;166:1583-1589. (Pubitemid 32114638)
25. Tsakadze NL, Sithu SD, Sen U, English WR, Murphy G, D'Souza SE. Tumor necrosis factor-α-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J Biol Chem. 2006;281:3157-3164. (Pubitemid 43845925)
26. Shi Q, Benderdour M, Lavigne P, Ranger P, Fernandes M. Evidence for two distinct pathways in TNFα-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients. Osteoarthritis Cartilage. 2006 15:300-308. (Pubitemid 46238245)
27. Pflugfelder SC, Stern ME. Future directions in therapeutic interventions for conjunctival inflammatory disorders. Curr Opin Allergy Clin Immunol. 2007;7:450-453.